The targeting construct introduced a mutation (TCC to GCC) resulting in the amino acid substitution of serine with alanine at position 180 (p.S180A) and inserted a loxP site flanked STOP/selection cassette. Cre-mediated recombination removed the STOP/selection cassette. (J:302502)